Allergy and Asthma Proceedings

Article	Citations
Hereditary angioedema: Epidemiology and burden of disease	72
The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?	56
Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome	55
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2	35
Definition and classification of hereditary angioedema	31
COVID-19 in children: Pathogenesis and current status	31
Patient perspectives on the treatment burden of injectable medication for hereditary angioedema	28
Triggers and short-term prophylaxis in patients with hereditary angioedema	28
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination	27
Treatment strategies for postviral olfactory dysfunction: A systematic review	27
Clinical presentation of hereditary angioedema	24
COVID-19 in a patient with severe asthma using mepolizumab	23
Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation	23
The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome	23
Hereditary angioedema: Special considerations in women	22
Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)	22
Hereditary angioedema and shared decision making	21
Hereditary angioedema: Differential diagnosis, diagnostic tests, and family screening	21
Hereditary angioedema: On-demand treatment of angioedema attacks	20
Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic	20
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?	20
Psychology and hereditary angioedema: A systematic review	19
Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies	18
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study	18
Hereditary angioedema: Special considerations in children	18

Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines	18
Effect of COVID-19 on hereditary angioedema activity and quality of life	18
Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis	18
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019	17
Assessing the cost and quality-of-life impact of on-demand‐only medications for adults with hereditary angioedema	17
Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies	17
Hereditary angioedema: Long-term prophylactic treatment	17
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications	17
Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience	16
Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis	16
Shifts in allergy practice in a COVID-19 world: Implications of pre‐COVID-19 national health care provider and patient surveys of treatments for nasal allergies	16
Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs	16
The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation	16
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	16
Tropomyosin: A panallergen that causes a worldwide allergic problem	15
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance	15
Treatment options for chronic rhinosinusitis with nasal polyps	15
Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema	15
Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticaria	14
Atopic dermatitis: Correlation of severity with allergic sensitization and eosinophilia	14
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management	14
Safety of subcutaneous allergen immunotherapy	14
Prior authorization delays biologic initiation and is associated with a risk of asthma exacerbations	14
Hereditary angioedema: Comprehensive management plans and patient support	13
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol	13
Hereditary angioedema: Investigational therapies and future research	13
Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study	13
Asthma in pregnancy	12
Accelerated/rush allergen immunotherapy	12
Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction	12
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs	12
Caregivers’ role in managing hereditary angioedema and perceptions of treatment-related burden	12
Efficacy and safety of sublingual allergen immunotherapy	12
Phenotypes and natural history of food protein‐induced enterocolitis syndrome in the east Mediterranean region	11
Idiopathic anaphylaxis: Diagnosis and management	11
Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease	11
Novel diagnostic techniques and therapeutic strategies for IgE‐mediated food allergy	11
Weighing the benefits and risks of oral immunotherapy in clinical practice	11
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease	10
Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis	10
Delayed allergic skin reactions to vaccines	10
The long COVID syndrome: A conundrum for the allergist/immunologist	10
Serum levels of specific immunoglobulin E toDermatophagoides pteronyssinusallergen components in patients with allergic rhinitis or/and asthma	10
Allergy to oak pollen in North America	9
Guidelines for management of hereditary angioedema: What is new? What is missing?	9
Short-term prophylaxis for children and adolescents with hereditary angioedema	9
Considerations for asthma management and viral transmission in the era of COVID-19	9
Patient perspectives on penicillin allergy and testing	9
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis	9
COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results	9

Clinical implications of asthma endotypes and phenotypes	9
Evaluation of drug patch tests in children	9
Long-term adherence strategies for allergen immunotherapy	9
Cat allergy in children and the effect of the COVID-19 pandemic	8
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	8
Allergen immunotherapy and shared decision-making	8
Obstructive sleep apnea is a determinant of asthma control independent of smoking, reflux, and rhinitis	8
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children	8
A 2-year-old girl with periprocedural anaphylaxis	8
Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria	8
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?	8
Longitudinal experience with treatment of acquired angioedema using tranexamic acid	8
Paucigranulocytic asthma: Do sputum macrophages matter?	8
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes	8
Epinephrine autoinjector prescription filling after pediatric emergency department discharge	8
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	8
A 48-year-old female with perioperative anaphylaxis	8
Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia	8
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose	7
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	7
A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children	7
Primary immunodeficiency diseases treated with immunoglobulin and associated comorbidities	7
56-year-old male with HIV and sudden cardiac arrest	7
How satisfactory is on-demand icatibant from the patients' perspective in real life?	7
Ideal body position for epinephrine autoinjector administration	7
COVID-19 in Italian children and adolescents: The role of allergy and asthma	7
Skin testing and drug challenge in the evaluation of drug hypersensitivity reactions	7
A 62-year-old man with new-onset bullae	7
Female sex as a risk factor for penicillin drug allergy in the inpatient setting	7
Venom allergen immunotherapy	7
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema	7
Criteria positive and criteria negative anaphylaxis, with a focus on undifferentiated somatoform idiopathic anaphylaxis: A review and case series	6
Chronic rhinosinusitis with nasal polyps management in the age of biologics	6
Evaluation of the peripheral blood eosinophil count as a predictor for fractional exhaled nitric oxide or bronchodilator reversibility test outcome	6
Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?	6
Applying personalized medicine to adult severe asthma	6
Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review	6
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis	6
Persistent urticarial rash in a newborn	6
A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure	6
Clinical phenotypes of childhood food allergies based on immune mechanisms: A multicenter study	6
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19	6
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	6
Prevalence of food allergy in the Chinese population: A systematic review and meta-analysis of population-based studies	6
A review of allergen immunotherapy in asthma	6
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis	6
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	6
Standardized allergen extracts for allergen immunotherapy	6
Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic	6
Effects of mechanical washing and drying on the removal of pet allergens	5
Mast cell activation syndrome: Myths and realities	5
Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non‐tertiary care private practice setup	5
The war on infectious diseases: COVID-19 vaccines and the public: Challenges and solutions	5
The impact of modernization on allergy and asthma development	5
Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment	5
Diagnostic value and safety of penicillin skin tests in children with immediate penicillin allergy	5
Studies of mitochondrial and nuclear DNA released from food allergen‐activated neutrophils. Implications for non‐IgE food allergy	5
The effect of the socioeconomic status on the measurement of asthma control	5
A masquerade of recurrent anaphylaxis	5
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma	5
Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema	5
The challenge of COVID-19 that permeates the practice of allergy/immunology	5
Pediatric sublingual allergen immunotherapy	5
Evaluation of anaphylaxis recurrence and adrenaline autoinjector use in childhood	5
Effect of prenatal phthalate exposure on childhood atopic dermatitis: A systematic review and meta-analysis	5
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy	5
The immunologic response to severe acute respiratory syndrome coronavirus 2	5
A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness	5
Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate	5
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist	5
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	5
Clinical features of anaphylaxis in children	5
Treatment options for moderate to severe atopic dermatitis	5
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities	5
Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape	5
Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals	4
Comparison of management options for specific antibody deficiency	4
Salivary microRNAs in pediatric eosinophilic esophagitis	4
Real-world mapping of allergy immunotherapy in the United States: The argument for improving adherence	4
Overview of secondary immunodeficiency	4

Future directions in allergen immunotherapy	4
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	4
Current and future management of chronic spontaneous urticaria and chronic inducible urticaria	4
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	4
The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond	4
Understanding of lipid transfer protein sensitization patterns and its clinical significance in children	4
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy	4
Current and emerging therapies for eosinophilic esophagitis	4
Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up	4
Management and referral patterns for new-onset chronic cough in primary care patients	4
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	4
Evaluation of nasal symptoms to distinguish eosinophilic from noneosinophilic nasal polyps based on peripheral blood	4
Baker's asthma in bread factory workers	4
Diverging trends of respiratory allergies and eczema in Greek schoolchildren: Six surveys during 1991‐2018	4
Long-term oral administration of transgenic rice containing cedar pollen T-cell epitopes potentially improves medication- and allergy-related quality-of-life scores	4
An 82-year-old man with new skin lesions after COVID-19 vaccination	4
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	4
Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment	4
Management of pediatric hereditary angioedema types 1 and 2: A search for international consensus	4
Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population	4
Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma	4
A brief history of allergen immunotherapy	4
Diagnostic value of thymus and activation-regulated chemokine and of periostin in eosinophilic asthma: A prospective study	4
Navigating the management complexity in long-term asymptomatic immunodeficiency	4
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	3
Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study	3
Caregiver perceptions and attitudes associated with oral immunotherapy on social media	3
Peptide immunotherapy for aeroallergens	3
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	3
Persistent airflow obstruction in inner-city children with asthma	3
Food-induced anaphylaxis in early childhood and factors associated with its severity	3
Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub	3
The COVID-19 impact on severe uncontrolled asthma costs and biologic use	3
Capturing total steroid burden in patients with atopic dermatitis and asthma	3
Diagnostic utility of basophil CD203c expression in β-lactam allergy	3
The return of the mixed respiratory bacterial vaccine	3
Essentials of allergen immunotherapy: A primer for the practitioner	3
Assessing cross-reactivity in allergen immunotherapy	3
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber	3
Diagnostic tests for primary immunodeficiency disorders: Classic and genetic testing	3
Development of anaphylaxis upon oral food challenge and drug provocation tests in pediatric patients	3
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist	3
Risk of asthma and/or wheezing in obese individuals with or without metabolic syndrome: From the Korea National Health and Nutrition Examination Survey data	3
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema	3
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria	3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy	3
Psychiatric comorbidity and quality of life in patients with drug hypersensitivity	3
Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge	3
Food protein‐induced enterocolitis syndrome: Current practices in oral food challenge	3
Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients	3
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	3
Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes	3
Atopic children are more susceptible to viral respiratory infection at the age of 2‐5 years old	3
Pediatric subcutaneous allergen immunotherapy	3
Interaction effects of asthma and rhinitis control on work productivity and activity impairment: A cross-sectional study	3
The evaluation of melatonin levels in chronic spontaneous urticaria: A case control study	3
Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns	3